cases

SmileDirectClub: When “Disruption” Outran Discipline

Lee McCabe

08 Nov 2025 — 1 min read

In the late 2010s, SmileDirectClub looked unstoppable. A direct-to-consumer revolution in orthodontics—cutting out the middleman, slashing prices, and promising a perfect smile from the comfort of your sofa. It was Silicon Valley swagger meets medical device economics, wrapped in pastel branding and influencer smiles.

Founded in 2014, the company exploded almost overnight. By 2018, revenue topped $750 million, backed by a valuation nearing $9 billion. Private equity (notably Clayton, Dubilier & Rice) jumped in, attracted by the irresistible combination of healthcare margins and consumer-tech growth rates. The model ticked every PE buzzword box: vertical integration, recurring revenue, digital-first acquisition, asset-light fulfillment.

On paper, it was beautiful. In reality, it was brittle.

SmileDirectClub was selling medical outcomes like they were mattresses. The company built an enormous marketing machine—hundreds of millions poured into TV, digital, influencer deals, even Times Square billboards. CAC (Customer Acquisition Cost) ballooned while retention and satisfaction quietly deteriorated.

Behind the glossy campaigns, operational cracks widened. Manufacturing delays, poor fit issues, and mounting regulatory scrutiny turned what was meant to be a tech-led disruptor into a clinical liability. Orthodontic boards pushed back, arguing the company was operating outside proper care standards. Class action suits followed.

Still, SmileDirect pressed the gas. Hypergrowth covered up fundamental flaws—until the IPO in 2019 ripped the curtain down. Shares plummeted 28% on day one. Within 12 months, they’d lost over 75% of value. By late 2023, the company filed for Chapter 11 bankruptcy protection.

The cautionary tale isn’t about ambition, it’s about discipline. Private equity and founders alike confused “scaling marketing” with “scaling a business.” CAC became a strategy, not a metric. Brand equity was treated as infinite. And when the flywheel slowed, there was nothing underneath to sustain it.

SmileDirectClub wanted to reinvent orthodontics. Instead, it proved that disruption without operational depth is just expensive noise.

News (w/e 1/9/26)

Eir Partners Closes $1 Billion Fund Focused on Healthcare Technology Miami-based Eir Partners closed its third fund at $1 billion, blowing past its $800 million target in just a few months. The raise reinforces a clear LP preference: specialist healthcare investors with repeatable playbooks still get paid attention, even as

Deals (w/e 1/9/26)

Veritas Capital Buys Majority Stake in Global Healthcare ExchangeVeritas Capital is acquiring a majority stake in Global Healthcare Exchange (GHX), the healthcare supply-chain software platform used by hospitals and suppliers across the U.S. GHX sits in the unglamorous but essential plumbing of healthcare, where scale and data matter more

Private equity has quietly entered a new sport: competitive talent hoarding.

Every firm now appears to be stockpiling operators the way children collected Pokémon cards. Operating Partners, Senior Advisors, Venture Partners, EIRs—hand out a title, add them to a slide, declare victory. LPs love the imagery. It signals “capability.” It looks sophisticated. It gives the impression of a tightly coordinated

AI isn’t coming for middle management. It’s already rearranging the job description.

The layer of people whose primary function is aggregating information, writing summaries, building decks, and “managing up” is about to feel the shift first. Not because AI is more insightful than they are, but because it’s cheaper, faster, and doesn’t need three pre-meetings to prepare for the meeting.

Read more

News (w/e 1/9/26)

Deals (w/e 1/9/26)

Private equity has quietly entered a new sport: competitive talent hoarding.

AI isn’t coming for middle management. It’s already rearranging the job description.